Boyu Li
Jiangnan University
5 Papers
3 Citations
Boyu Li is an academic researcher from Jiangnan University. The author has contributed to research in topics: Bleomycin & Inflammation. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Dehydrocostus Lactone Suppresses LPS-induced Acute Lung Injury and Macrophage Activation through NF-κB Signaling Pathway Mediated by p38 MAPK and Akt.
Yunjuan Nie,Zhongxuan Wang,Gaoshang Chai,Yue Xiong,Boyu Li,Hui Zhang,Ruiting Xin,Xiaohang Qian,Zihan Tang,Jiajun Wu,Peng Zhao +10 more
TL;DR: DHL significantly attenuated LPS-induced pathological injury and reduced cytokines expression in the lung and NF-κB, p38 MAPK/MK2 and Akt signaling molecules were also involved in the anti-inflammatory effect.
115
S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice.
Yunjuan Nie,Kaikai Yu,Boyu Li,Yudong Hu,Hui Zhang,Ruiting Xin,Yue Xiong,Peng Zhao,Gaoshang Chai +8 more
TL;DR: Findings indicate that SAC might mediate AKT/NF-κB signaling pathway to inhibit BLM-induced pulmonary fibrosis and support the potential role of SAC as an anti-pulmonary fibrosis agent.
22
Dach1 Deficiency Drives Alveolar Epithelium Apoptosis in Pulmonary Fibrosis via Modulating C-Jun/Bim Activity.
Yan Lu,K. Mary Tang,Shanshan Wang,Zhen Tian,Yan G Fan,Boyu Li,Meijia Wang,Jianping Zhao,Jungang Xie +8 more
TL;DR: In this article , the lungs collected from PF patients and mice of Bleomycin (BLM)-treated were characterized by low expression of Dachshund homolog 1 (Dach1), especially in AECII.
11
Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation
Yunjuan Nie,Dan Zhang,Zhe Wu Jin,Boyu Li,Xue Wang,Huilian Che,Yaqian You,Xiaohang Qian,Yang Zhang,Peng Zhao,Gaoshang Chai +10 more
TL;DR: The data revealed that lanatoside C alleviated BLM‐induced pulmonary fibrosis in mice via attenuation of growth and differentiation of fibroblasts, suggesting that it has potential as a candidate therapy for PF patients.
5
Sphingosine-1-Phosphate Receptor 4 Attenuates Neutrophilic Airway Inflammation in Experimental Asthma via Repressing Proinflammatory Macrophage Activation
Shanshan Wang,Zhe-Yu Tian,Yan Lu,Zhenli Huang,Yan G Fan,Boyu Li,Hongyan Zheng,Xiaojie Wu,Meijia Wang,Jianping Zhao,Jungang Xie +10 more
TL;DR: In this paper , the sphingosine-1-phosphate receptor 4 (S1PR4) deficiency aggravated the OVA/LPS-induced pulmonary inflammation in mice along with a significant up-regulation in M1 macrophage activation.